Sore Throat News and Research

RSS

The new Omicron subvariant BA.2: what we know so far

Presently, an Omicron subvariant known as BA.2, first identified in late 2021, has made headlines due to its rapid spread.

26 Jan 2022

Eligible adults urged to take part in world-first COVID-19 study of antivirals

Adults over the age of 50 or with an underlying health condition who test positive for COVID-19 are being urged to sign up for a world-first COVID-19 study which is providing life-saving antivirals to thousands of people.

24 Jan 2022

SARS-CoV-2 Omicron associated with fewer lower and more upper respiratory tract symptoms

Researchers assess the impact of the SARS-CoV-2 Omicron variant of concern on symptoms of SARS-CoV-2 infection.

23 Jan 2022

Effects of post-acute COVID-19 on physical and mental health in women

The current study attempts to measure the difference in mood, functional status, and leisure-time physical activity in women with a history of COVID-19.

17 Jan 2022

Insignificant homology of SARS-CoV-2 spike sequences to myocarditis-associated antigens

Researchers determine whether sequences within SARS-CoV-2 could lead to an immune response to autoantigens associated with autoimmune myocarditis.

13 Jan 2022

What patients can learn with confidence from one negative rapid test (hint: very little)

Julie Ann Justo, an infectious disease clinical pharmacist for a South Carolina hospital system, hoped Christmas week would finally be the time her family could safely gather for a reunion.

13 Jan 2022

Lack of evidence cross-reactive adaptive immune response is mechanism underlying COVID vaccine-induced myocarditis

Recently, the researchers from the USA, in their study published in the journal EBioMedicine, have conducted a sequence identity comparison and 3D protein structure comparison between the SARS-CoV-2 spike protein-derived peptides/protein and myocarditis-associated antigens and have found no significant enrichment in the frequency of spike-derived peptides similar to myocarditis-associated antigens that could have resulted in adaptive autoimmune responses leading to myocarditis.

12 Jan 2022

Real-world effectiveness of three COVID-19 vaccines

Researchers from IQVIA Real-World Solutions have investigated how effective these vaccines are against severe disease.

11 Jan 2022

Researchers investigate SARS-CoV-2 specific inflammatory response

New research can confirm that while some of the response from monocytes to SARS-CoV-2 is generic to virus infection, most of it SARS-CoV-2 specific, especially proinflammatory responses.

7 Jan 2022

Reinfection with SARS-CoV-2 in children

These findings bear out earlier reports that COVID-19 is less frequent and severe in children than adults.

7 Jan 2022

Moderna announces initiation of Phase 1 study of its mRNA-1189 EBV vaccine candidate

Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines, today announced the first participant has been dosed in the Phase 1 study of mRNA-1189, the Company's Epstein-Barr Virus vaccine candidate.

7 Jan 2022

Loss of smell is the best predictor of COVID-19

A large international team of researchers has conducted a crowdsourced cross-sectional study, in which they have investigated the reliability of the olfactory loss (or loss of smell, or anosmia) as a predictor of coronavirus disease 19 (COVID-19).

30 Dec 2021

New report on 1.23 million breakthrough symptomatic SARS-CoV-2 infections by vaccine

A new research letter evaluates whether the estimated vaccine effectiveness changes against infection over time.

28 Dec 2021

Children with isolated symptoms as likely as those with multiple symptoms to test COVID-19 positive

A new study compares rates of coronavirus disease 2019 infection in children who reported no symptoms, one isolated symptom, or two or more symptoms during the circulation of the Delta variant.

21 Dec 2021

Severity of SARS-CoV-2 compared to other human coronaviruses in children

Researchers observed that symptom presentation of SARS-CoV-2 infections at the community level was very similar to that of endemic human coronavirus infections.

14 Dec 2021

Community mask usage reduces symptomatic COVID seroprevalence in Bangladesh

A new Science preprint explores the effectiveness of universal masking in reducing the incidence of symptomatic disease.

7 Dec 2021

An analysis of risk factors and symptom presentation among groups at risk for SARS-CoV-2 infection

The study, published on the pre-print server medRxiv*, analyzed the specific linkages between the COVID-19 patients belonging to the three risk groups with the overall COVID-19 patients and compared symptoms between and within the risk groups.

6 Dec 2021

COVID symptom attestation tool for health care workers helps protect patients and co-workers

Any fever or chills? Cough? Shortness of breath? Answering these questions and others has become a familiar part of daily life during the pandemic.

6 Dec 2021

A case of post-vaccination MIS in an adult without prior SARS-CoV-2 infection

A new case study on the report of multisystem inflammatory syndrome (MISC) in a 22-year-old woman in South Korea after vaccination.

5 Dec 2021

UK study finds COVID-19 from Delta and Alpha infections are clinically similar

Research suggests that COVID-19 from Delta or Alpha infections is clinically similar, yet Delta is more transmissible than Alpha.

30 Nov 2021

Sore Throat News and Research

The new Omicron subvariant BA.2: what we know so far

Eligible adults urged to take part in world-first COVID-19 study of antivirals

SARS-CoV-2 Omicron associated with fewer lower and more upper respiratory tract symptoms

Effects of post-acute COVID-19 on physical and mental health in women

Insignificant homology of SARS-CoV-2 spike sequences to myocarditis-associated antigens

What patients can learn with confidence from one negative rapid test (hint: very little)

Lack of evidence cross-reactive adaptive immune response is mechanism underlying COVID vaccine-induced myocarditis

Real-world effectiveness of three COVID-19 vaccines

Researchers investigate SARS-CoV-2 specific inflammatory response

Reinfection with SARS-CoV-2 in children

Moderna announces initiation of Phase 1 study of its mRNA-1189 EBV vaccine candidate

Loss of smell is the best predictor of COVID-19

New report on 1.23 million breakthrough symptomatic SARS-CoV-2 infections by vaccine

Children with isolated symptoms as likely as those with multiple symptoms to test COVID-19 positive

Severity of SARS-CoV-2 compared to other human coronaviruses in children

Community mask usage reduces symptomatic COVID seroprevalence in Bangladesh

An analysis of risk factors and symptom presentation among groups at risk for SARS-CoV-2 infection

COVID symptom attestation tool for health care workers helps protect patients and co-workers

A case of post-vaccination MIS in an adult without prior SARS-CoV-2 infection

UK study finds COVID-19 from Delta and Alpha infections are clinically similar

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News